Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Melinta Therapeutics, Inc. (MLNTQ) had Debt to Capital Ratio of 0.37 for the most recently reported fiscal year, ending 2018-12-31.
| Income Statement Financials | |
$96.43M |
|
$-157.19M |
|
$41.06M |
|
$55.37M |
|
$254.87M |
|
$-158.44M |
|
$1.24M |
|
$-157.19M |
|
$-157.19M |
|
$-157.19M |
|
$-157.19M |
|
$-157.19M |
|
$-157.19M |
|
$-158.44M |
|
$-141.53M |
|
9.18M |
|
9.18M |
|
$-17.12 |
|
$-17.12 |
|
| Balance Sheet Financials | |
$149.48M |
|
$1.59M |
|
$292.11M |
|
$441.59M |
|
$133.61M |
|
$110.48M |
|
$117.92M |
|
$251.53M |
|
$190.06M |
|
$-39.13M |
|
$190.06M |
|
11.20M |
|
| Cash Flow Statement Financials | |
$-171.54M |
|
$-170.07M |
|
$295.04M |
|
$128.59M |
|
$82.01M |
|
$-46.58M |
|
$3.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.37 |
0.58 |
|
57.42% |
|
-164.30% |
|
-164.30% |
|
-146.77% |
|
-163.01% |
|
-163.01% |
|
$-173.24M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.99 |
|
4.29 |
|
85.11 |
|
-82.70% |
|
401.70% |
|
-35.60% |
|
-52.30% |
|
$16.96 |
|
$-18.87 |
|
$-18.68 |
|